XNAS · GCTK
+2.43% · +$0.0089 · Vol 433.1K
Market closed · last close 4:00 PM ET · price as of 19:51:35 ET
GlucoTrack, Inc. Common Stock

GlucoTrack, Inc. Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$0.3750
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is GCTK moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for GCTK are being assembled.
About GlucoTrack, Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2000
Employees
15
Country
US

GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.3663
Day high
$0.3896
Day low
$0.3487
Previous close
$0.3661
52W high
$0.4100
-8.54% from high
52W low
$0.3125
64% of range
Market cap
$2.3M
P/E
0.02×
EPS
$16.24
Shares out
6.3M
Volume
433.1K
VWAP
$0.3581
Price history computed in-house
1W
+20.00%
1M
+5.99%
SMA 50 $0.3571 · above
SMA 200 $0.3571 · above
52W position 64%
Veridion warehouse edge

Warehouse intelligence for GCTK.

Veridion Score
33
0: 471: 612: 253: Not reported4: Not reported5: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

GCTK insider activity

GlucoTrack, Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for GCTK.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

GCTK contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GCTK in this window.
Lobbying spend

GCTK lobbying filings, year to date.

Registered lobbying filings matched to GlucoTrack, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GCTK in this window.
Latest news · GCTK
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for GCTK.
Options
Sovereign unlock shows live options positioning for GCTK.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.